The global prevalence of sarcopenic obesity in older adults was 7%, and non-pharmacological interventions, particularly exercise, significantly improved muscle mass, strength, and body fat percentage.
Meta-Analysis
What is the global prevalence of sarcopenic obesity in older adults, and do non-pharmacological interventions improve its components?
Sarcopenic obesity has a global prevalence of 7% in older adults, and non-pharmacological interventions, particularly exercise, effectively improve muscle mass, muscle strength, and reduce body fat.
OBJECTIVES: Sarcopenic obesity (SO) is a syndrome increasingly recognized in older adults. We aimed to conduct a systematic review and a meta-analysis to reveal the global prevalence of SO in olders, and the effects of non-pharmacological interventions on the different components of SO. METHODS: statistic. Low muscle mass(MM) or low MM plus low muscle strength(MS) were used for the diagnosis of sarcopenia, body fat percentage (BF%), waist circumference (WC) or body mass index (BMI) parameters were used for the diagnosis of obesity. Intervention studies included exercise-based interventions, nutritional-based interventions,combined interventions, and electrical acupuncture. RESULTS: The global SO prevalence was 7%. The prevalence of SO, depending on the sarcopenia definition, was 8% and 5% due to MM and MM plus MS, respectively. The prevalence of SO, depending on the definition of obesity, was 8%, 5%, and 7% according to BF%, BMI, and WC, respectively. In the overall intervention groups, BF% was reduced, MS and MM was increased. Exercise appears to have a more pronounced effect on sarcopenia. CONCLUSION: The global prevalence of SO in the older population was 7%. MS and MM improved, and BF% decreased significantly in the overall intervention groups, with a more pronounced effect in exercise intervention studies.
Ayçiçek et al. (Sun,) conducted a meta-analysis in Sarcopenic obesity. Non-pharmacological interventions was evaluated on Global prevalence of sarcopenic obesity. The global prevalence of sarcopenic obesity in older adults was 7%, and non-pharmacological interventions, particularly exercise, significantly improved muscle mass, strength, and body fat percentage.